Table 7.
Characteristics of the Patients Treated or Not With LMWH Before Oral Anticoagulants
| Not Treated With LMWH (n=1050) | Treated With LMWH (n=111) | P Value | |
|---|---|---|---|
| Age, y | 75.7±9.9 | 74.0±10.0 | |
| Sex, male | 473 (45.0) | 64 (57.6) | 0.012 |
| NIHSS on admission | 7.5±6.0 | 8.5±7.1 | |
| Diabetes mellitus | 201 (19.1) | 21 (18.9) | |
| Hypertension | 805 (76.7) | 79 (71.2) | |
| Hyperlipidemia | 369 (35.1) | 40 (36.0) | |
| Paroxysmal atrial fibrillation | 513 (48.9) | 52 (46.8) | |
| History stroke/TIA | 272 (25.9) | 31 (27.9) | |
| Current smoker | 117 (11.1) | 14 (12.6) | |
| Alcoholism | 66 (6.3) | 7 (6.3) | |
| History congestive heart failure | 164 (15.6) | 15 (13.5) | |
| History myocardial infarction | 119 (11.3) | 14 (12.6) | |
| Lesion sizea | |||
| Small | 409 (41.6) | 40 (36.7) | |
| Leukoaraiosis | 615 (58.6) | 60 (54.0) | |
| CHA2DS2‐VASc score after index stroke | |||
| >4 | 782 (74.5) | 75 (68.7) | |
Data are shown as mean±SD or n (%). LMWH indicates low‐molecular‐weight heparin; NIHSS, National Institutes of Health Stroke Scale; TIA, transient ischemic attack.
a
1063 patients.